Literature DB >> 2549034

Human deoxycytidine kinase. Sequence of cDNA clones and analysis of expression in cell lines with and without enzyme activity.

S H Huang1, J M Tomich, H Wu, A Jong, J Holcenberg.   

Abstract

Deoxycytidine kinase (dC kinase) is the rate-limiting enzyme in the anabolism of important anticancer and retroviral nucleoside derivatives. Its activity is often decreased in resistance to these drugs. To analyze the structure, function, and control of this clinically important enzyme we isolated 15 cDNA clones for human deoxycytidine kinase from lambda gt11 thymus and Molt 4 libraries. Four clones were sequenced. The largest clone is 2.9 kilobases and codes for a 626-amino acid open reading frame. The DNA and deduced amino acid sequence of the human dC kinase clones are homologous with a previously unidentified murine cDNA clone p3.4J (EMBL:MM34j) reported to be related to granulocyte-macrophage colony-stimulating factor. Deoxycytidine kinase also has cysteine-rich regions that are homologous with thioredoxin, the beta subunit of prolyl 4-hydroxylase, phosphoinositide-specific phospholipase C, thyroid hormone-binding protein, and protein disulfide isomerase. No differences were seen in the amount and size of deoxycytidine kinase protein and mRNA between CCRF/CEM and L1210 leukemic cell lines that express and do not express enzyme activity. Genomic restriction fragments were similar between the active and inactive CCRF/CEM cell lines. These data suggest that the cells deficient in dC kinase activity have a small defect in the structural gene.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2549034

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  3 in total

1.  A simple method for direct cloning cDNA sequence that flanks a region of known sequence from total RNA by applying the inverse polymerase chain reaction.

Authors:  S H Huang; Y Y Hu; C H Wu; J Holcenberg
Journal:  Nucleic Acids Res       Date:  1990-04-11       Impact factor: 16.971

2.  Cloning and expression of human deoxycytidine kinase cDNA.

Authors:  E G Chottiner; D S Shewach; N S Datta; E Ashcraft; D Gribbin; D Ginsburg; I H Fox; B S Mitchell
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-15       Impact factor: 11.205

3.  Insights from HuR biology point to potential improvement for second-line ovarian cancer therapy.

Authors:  Yu-Hung Huang; Weidan Peng; Narumi Furuuchi; James B DuHadaway; Masaya Jimbo; Andrea Pirritano; Charles J Dunton; Gary S Daum; Benjamin E Leiby; Jonathan R Brody; Janet A Sawicki
Journal:  Oncotarget       Date:  2016-04-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.